BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36951259)

  • 1. A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.
    Esperanza-Cebollada E; Gómez-González S; Perez-Jaume S; Vega-García N; Vicente-Garcés C; Richarte-Franqués M; Rives S; Català A; Torrebadell M; Camós M
    Br J Haematol; 2023 Jul; 202(1):96-110. PubMed ID: 36951259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational analysis of a microRNA signature for poor prognosis suggests a microRNA-controlled stemness pathway in paediatric acute leukaemia.
    Erkeland SJ
    Br J Haematol; 2023 Jul; 202(1):11-12. PubMed ID: 36994809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
    Shi M; Xu G
    BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
    Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
    J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia.
    Kumar S; Bakhshi S
    Indian J Med Res; 2016 Dec; 144(6):807-814. PubMed ID: 28474617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia.
    Elsayed AH; Rafiee R; Cao X; Raimondi S; Downing JR; Ribeiro R; Fan Y; Gruber TA; Baker S; Klco J; Rubnitz JE; Pounds S; Lamba JK
    Leukemia; 2020 Mar; 34(3):735-745. PubMed ID: 31645648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.
    Karol SE; Coustan-Smith E; Cao X; Shurtleff SA; Raimondi SC; Choi JK; Ribeiro RC; Dahl GV; Bowman WP; Taub JW; Degar B; Leung W; Downing JR; Pui CH; Rubnitz JE; Campana D; Inaba H
    Br J Haematol; 2015 Jan; 168(1):94-101. PubMed ID: 25164427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.
    Rubnitz JE; Inaba H; Dahl G; Ribeiro RC; Bowman WP; Taub J; Pounds S; Razzouk BI; Lacayo NJ; Cao X; Meshinchi S; Degar B; Airewele G; Raimondi SC; Onciu M; Coustan-Smith E; Downing JR; Leung W; Pui CH; Campana D
    Lancet Oncol; 2010 Jun; 11(6):543-52. PubMed ID: 20451454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
    Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
    Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 17-gene stemness score for rapid determination of risk in acute leukaemia.
    Ng SW; Mitchell A; Kennedy JA; Chen WC; McLeod J; Ibrahimova N; Arruda A; Popescu A; Gupta V; Schimmer AD; Schuh AC; Yee KW; Bullinger L; Herold T; Görlich D; Büchner T; Hiddemann W; Berdel WE; Wörmann B; Cheok M; Preudhomme C; Dombret H; Metzeler K; Buske C; Löwenberg B; Valk PJ; Zandstra PW; Minden MD; Dick JE; Wang JC
    Nature; 2016 Dec; 540(7633):433-437. PubMed ID: 27926740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
    Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
    Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
    Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
    Front Immunol; 2020; 11():582915. PubMed ID: 33519805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia.
    Bai L; Zhang YZ; Yan CH; Wang Y; Xu LP; Zhang XH; Zhang LP; Huang XJ; Cheng YF
    BMC Cancer; 2022 Aug; 22(1):896. PubMed ID: 35974319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurable residual disease testing in acute myeloid leukaemia.
    Hourigan CS; Gale RP; Gormley NJ; Ossenkoppele GJ; Walter RB
    Leukemia; 2017 Jul; 31(7):1482-1490. PubMed ID: 28386105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.
    Buldini B; Rizzati F; Masetti R; Fagioli F; Menna G; Micalizzi C; Putti MC; Rizzari C; Santoro N; Zecca M; Disarò S; Rondelli R; Merli P; Pigazzi M; Pession A; Locatelli F; Basso G
    Br J Haematol; 2017 Apr; 177(1):116-126. PubMed ID: 28240765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.
    Zampini M; Bisio V; Leszl A; Putti MC; Menna G; Rizzari C; Pession A; Locatelli F; Basso G; Tregnago C; Pigazzi M
    Br J Haematol; 2018 Oct; 183(2):298-301. PubMed ID: 28961307
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
    Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
    J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
    Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
    Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.